Skip to main content
Log in

Protective effect of Schisandrae chinensis oil on pancreatic β-cells in diabetic rats

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Islet cell dysfunction in type 2 diabetes is primarily attributed to increased apoptosis of pancreatic β-Cells. The aim of the present study was to investigate the effects of Schisandrae chinensis oil on pancreatic β-Cells in type 2 diabetes mellitus rats and the associated molecular mechanisms of action. Wistar rats were randomly divided into diabetic rats and control rats, diabetic rats treated with Schisandrae chinensis oil (1 mg/kg), and control rats treated with Schisandrae chinensis oil. The serum fasting blood glucose, insulin, total cholesterol, and triglyceride levels along with MDA content, SOD and CAT activities in pancreatic tissues were measured. TUNEL was used to observe the apoptosis of rat pancreatic cells. Western blot was used to determine specific protein expression. The results showed that the oil significantly decreased fasting blood glucose, total cholesterol, triglyceride levels as well as the pancreatic MDA, but increased SOD and CAT activities. The protein expression of Bcl-2, PDX-1, GLUT-2, and GCK but not caspase 3 was significantly enhanced in the oil-treated rats compared with diabetic rats. However, Bax content was not significantly different between the control and DM groups. Schisandra chinensis oil improves pancreatic β-cell function by enhancing antioxidant potential of the pancreas, upregulating the expression of anti-apoptotic genes, increasing expression of glucose metabolism, and delaying islet cell apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. H. Sone, Y. Kagawa, Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48(1), 58–67 (2005). doi:10.1007/s00125-004-1605-2

    Article  CAS  PubMed  Google Scholar 

  2. P. Marchetti, M. Bugliani, U. Boggi, M. Masini, L. Marselli, The pancreatic beta cells in human type 2 diabetes. Adv. Exp. Med. Biol. 771, 288–309 (2012)

    PubMed  Google Scholar 

  3. B. Thorens, The required beta cell research for improving treatment of type 2 diabetes. J. Intern. Med. 274(3), 203–214 (2013). doi:10.1111/joim.12096

    Article  CAS  PubMed  Google Scholar 

  4. M.O. Larsen, Beta-cell function and mass in type 2 diabetes. Dan. Med. Bull. 56(3), 153–164 (2009)

    PubMed  Google Scholar 

  5. C.P. Commission, China Pharmacopoeia. In vol. 1. (Chemical Industry Press, Beijing 2010), pp. 61–62

  6. A. Panossian, G. Wikman, Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J. Ethnopharmacol. 118(2), 183–212 (2008). doi:10.1016/j.jep.2008.04.020

    Article  PubMed  Google Scholar 

  7. D.Y. Kwon, S. da Kim, H.J. Yang, S. Park, The lignan-rich fractions of Fructus Schisandrae improve insulin sensitivity via the PPAR-gamma pathways in in vitro and in vivo studies. J. Ethnopharmacol. 135(2), 455–462 (2011). doi:10.1016/j.jep.2011.03.037

    Article  CAS  PubMed  Google Scholar 

  8. C. Wang, J. Li, X. Lv, M. Zhang, Y. Song, L. Chen, Y. Liu, Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin. Eur. J. Pharmacol. 620(1–3), 131–137 (2009). doi:10.1016/j.ejphar.2009.07.027

    Article  CAS  PubMed  Google Scholar 

  9. A. Zywert, K. Szkudelska, T. Szkudelski, Inhibition of phosphodiesterase 3B in insulin-secreting cells of normal and streptozocin-nicotinamide-induced diabetic rats implications for insulin secretion. J. Physiol. Pharmacol. 65(3), 425–433 (2014)

    CAS  PubMed  Google Scholar 

  10. W. Xie, L. Du, Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes. Metab. 13(4), 289–301 (2011). doi:10.1111/j.1463-1326.2010.01336.x

    Article  CAS  PubMed  Google Scholar 

  11. K.F. Cai, Z.C. Qin, Y.L. Wang, Effects of Fructus Schisandrae oil on islet cell morphology and function of diabetic mice. Chin. J. Tradit. Med. Sci. Technol. 14(3), 177–178 (2007)

    Google Scholar 

  12. K.F. Cai, Z.C. Qin, Y.L. Wang, Effects of Fructus Schisandrae oil on antioxidant and the expression of glucose transporter protein 4 mRNA of diabetic mice. Chin. Arch. Tradit. Chin. Med. 24(7), 1199–1200 (2006)

    Google Scholar 

  13. L.P. An, Y.P. Wang, X.M. Liu, Effect of Fructus Schisandrae oil on blood glucose of type 2 diabetic rats induced by Streptozotocin. Chin. Tradit. Herb. Drugs 43(3), 52–556 (2012)

    Google Scholar 

  14. J.H. Yki, Pathogenesis of noninsulin dependent diabetes mellitus. Lancet 343(8889), 91–95 (1994)

    Article  Google Scholar 

  15. W.H. Kim, J.W. Lee, Y.H. Suh, S.H. Hong, J.S. Choi, J.H. Lim, J.H. Song, B. Gao, M.H. Jung, Exposure to chronic high glucose induces beta-cell apoptosis through decreased interaction of glucokinase with mitochondria: downregulation of glucokinase in pancreatic beta-cells. Diabetes 54(9), 2602–2611 (2005)

    Article  CAS  PubMed  Google Scholar 

  16. M. Bensellam, D.R. Laybutt, J.C. Jonas, The molecular mechanisms of pancreatic beta-cell glucotoxicity: recent findings and future research directions. Mol. Cell. Endocrinol. 364(1–2), 1–27 (2012). doi:10.1016/j.mce.2012.08.003

    Article  CAS  PubMed  Google Scholar 

  17. T. van de Weijer, V.B. Schrauwen-Hinderling, P. Schrauwen, Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc. Res. 92(1), 10–18 (2011). doi:10.1093/cvr/cvr212

    Article  PubMed  Google Scholar 

  18. J.R. Zierath, A. Krook, H. Wallberg-Henriksson, Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43(7), 821–835 (2000). doi:10.1007/s001250051457

    Article  CAS  PubMed  Google Scholar 

  19. U.K. Prospective Diabetes Study Group, U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 44(11), 1249–1258 (1995)

    Article  Google Scholar 

  20. G.C. Weir, D.R. Laybutt, H. Kaneto, S. Bonner-Weir, A. Sharma, Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 50(Suppl 1), S154–S159 (2001)

    Article  CAS  PubMed  Google Scholar 

  21. J.D. Johnson, N.T. Ahmed, D.S. Luciani, Z. Han, H. Tran, J. Fujita, S. Misler, H. Edlund, K.S. Polonsky, Increased islet apoptosis in Pdx1 ± mice. J. Clin. Investig. 111(8), 1147–1160 (2003). doi:10.1172/JCI16537

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. W. Kim, J.M. Egan, The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol. Rev. 60(4), 470–512 (2008). doi:10.1124/pr.108.000604

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. F. Al-Quobaili, M. Montenarh, Pancreatic duodenal homeobox factor-1 and diabetes mellitus type 2 (review). Int. J. Mol. Med. 21(4), 399–404 (2008)

    CAS  PubMed  Google Scholar 

  24. R. Singh, E.R. Pearson, P.M. Clark, A.T. Hattersley, The long-term impact on offspring of exposure to hyperglycaemia in utero due to maternal glucokinase gene mutations. Diabetologia 50(3), 620–624 (2007). doi:10.1007/s00125-006-0541-8

    Article  CAS  PubMed  Google Scholar 

  25. R.N. Kulkarni, U.S. Jhala, J.N. Winnay, S. Krajewski, M. Montminy, C.R. Kahn, PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J. Clin. Investig. 114(6), 828–836 (2004). doi:10.1172/JCI21845

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. H. Kaneto, T. Miyatsuka, D. Kawamori, T.A. Matsuoka, Pleiotropic roles of PDX-1 in the pancreas. Rev. Diabet. Stud. 4(4), 209–225 (2007). doi:10.1900/RDS.2007.4.209

    Article  PubMed Central  PubMed  Google Scholar 

  27. H. Kaneto, T. Miyatsuka, T. Shiraiwa, K. Yamamoto, K. Kato, Y. Fujitani, T.A. Matsuoka, Crucial role of PDX-1 in pancreas development, beta-cell differentiation, and induction of surrogate beta-cells. Curr. Med. Chem. 14(16), 1745–1752 (2007)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was funded by project “2013-199” supported by the Education Department of Jilin Province, project “201262503” supported by Sci-tech Department of Jilin City and project “20122082” the Healthe Department of Jilin Province.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Fuxiang Ding or Peige Du.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

An, L., Wang, Y., Wang, C. et al. Protective effect of Schisandrae chinensis oil on pancreatic β-cells in diabetic rats. Endocrine 48, 818–825 (2015). https://doi.org/10.1007/s12020-014-0375-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-014-0375-y

Keywords

Navigation